These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8710082)

  • 21. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pallidothalamic-projecting neurons in Macaca fascicularis co-express GABAergic and glutamatergic markers as seen in control, MPTP-treated and dyskinetic monkeys.
    Conte-Perales L; Rico AJ; Barroso-Chinea P; Gómez-Bautista V; Roda E; Luquin N; Sierra S; Lanciego JL
    Brain Struct Funct; 2011 Nov; 216(4):371-86. PubMed ID: 21512896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
    Vila M; Marin C; Ruberg M; Jimenez A; Raisman-Vozari R; Agid Y; Tolosa E; Hirsch EC
    J Neurochem; 1999 Jul; 73(1):344-52. PubMed ID: 10386987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion.
    Nielsen KM; Soghomonian JJ
    Synapse; 2003 Sep; 49(4):246-60. PubMed ID: 12827644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.
    DiCaudo C; Riverol M; Mundiñano IC; Ordoñez C; Hernández M; Marcilla I; Luquin MR
    PLoS One; 2012; 7(11):e50842. PubMed ID: 23226401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
    Calon F; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Exp Neurol; 2000 May; 163(1):191-9. PubMed ID: 10785458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.
    Carta AR; Pinna A; Tronci E; Morelli M
    Neurology; 2003 Dec; 61(11 Suppl 6):S39-43. PubMed ID: 14663008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
    Riahi G; Morissette M; Samadi P; Parent M; Di Paolo T
    Biochem Pharmacol; 2013 Oct; 86(7):970-8. PubMed ID: 23954709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5995-9. PubMed ID: 3497401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat.
    Mercugliano M; Soghomonian JJ; Qin Y; Nguyen HQ; Feldblum S; Erlander MG; Tobin AJ; Chesselet MF
    J Comp Neurol; 1992 Apr; 318(3):245-54. PubMed ID: 1583162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat.
    Soghomonian JJ; Chesselet MF
    Synapse; 1992 Jun; 11(2):124-33. PubMed ID: 1626311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Di Paolo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation.
    Betarbet R; Porter RH; Greenamyre JT
    J Neurochem; 2000 Mar; 74(3):1166-74. PubMed ID: 10693949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Doudet D; Gross C; Lebrun-Grandié P; Bioulac B
    C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.
    Pirker W; Tedroff J; Pontén H; Gunne L; Andrén PE; Hurd YL
    Exp Neurol; 2001 May; 169(1):122-34. PubMed ID: 11312565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys.
    Parent A; Lavoie B; Smith Y; Bédard P
    Adv Neurol; 1990; 53():111-6. PubMed ID: 1978512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.